Literature DB >> 15098214

Excretion of collagen derived peptides is increased in women with stress urinary incontinence.

Leslie Kushner1, Mahesh Mathrubutham, Tracey Burney, Robert Greenwald, Gopal Badlani.   

Abstract

AIMS: The objective of this study was to demonstrate that weakened pelvic floor support of the lower genitourinary tract in women with stress urinary incontinence (SUI) is due to increased collagenolysis. When fibrillar collagen is degraded, pyridinium (PYD) crosslinks are released and excreted in the urine. Degradation of collagen also results in peptide fragments of various lengths which are excreted in the urine. Degradation of mature fibrillar collagen and collagen which has not been crosslinked can be assessed independently by measurement of both PYD and collagen-derived peptides in the urine.
METHODS: Twenty-four hour urine collections were obtained from women with SUI (n = 23) and women without urinary incontinence (n = 39). Urinary PYD concentration was assayed by ELISA. The urinary concentration of helical peptide alpha1 (I) 620-633 fragments derived from collagen was assayed by competitive enzyme immunoassay. Values were normalized to creatinine.
RESULTS: The mean urine PYD concentration for women with SUI (110.8 +/- 19.7 nM/mM creatinine) was not significantly different than that for women without SUI (85.2 +/- 13.7 nM/mM creatinine). The mean urine concentration of helical peptide alpha1 (I) 620-633 for women with SUI (0.80 +/- 0.13 microg/mg creatinine) was significantly (P < 0.02) higher than that for women without SUI (0.49 +/- 0.06 microg/mg creatinine).
CONCLUSIONS: These data suggest that collagenolytic activity in women with SUI is elevated compared to continent controls, as measured by urinary helical peptide alpha1 (I) 620-633 excretion. The lack of difference in urinary PYD excretion between the two populations suggests that the increased collagenolytic activity in women with SUI, compared to continent controls, is restricted to uncrosslinked collagen. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098214     DOI: 10.1002/nau.10174

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  9 in total

Review 1.  Pelvic organ prolapse: demographics and future growth prospects.

Authors:  Harold P Drutz; May Alarab
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06

Review 2.  The use of synthetic sub-urethral slings in the treatment of female stress urinary incontinence.

Authors:  Andrew Feifer; Jacques Corcos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-04-27

Review 3.  Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.

Authors:  Niall F Davis; F Kheradmand; T Creagh
Journal:  Int Urogynecol J       Date:  2012-12-08       Impact factor: 2.894

Review 4.  Vaginal Mesh Exposure Presentation, Evaluation, and Management.

Authors:  Joao P Zambon; Gopal H Badlani
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

Review 5.  Signs of herniosis in women with vaginal prolapse and/or stress incontinence.

Authors:  R C Read
Journal:  Hernia       Date:  2008-04-16       Impact factor: 4.739

6.  Pelvic organ prolapse and stress urinary incontinence: A review of etiological factors.

Authors:  Payal D Patel; Kaytan V Amrute; Gopal H Badlani
Journal:  Indian J Urol       Date:  2007-04

7.  Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review.

Authors:  Hemendra N Shah; Gopal H Badlani
Journal:  Indian J Urol       Date:  2012-04

Review 8.  Stem cells for stress urinary incontinence: the adipose promise.

Authors:  Régis Roche; Franck Festy; Xavier Fritel
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

Review 9.  Molecular Processes in Stress Urinary Incontinence: A Systematic Review of Human and Animal Studies.

Authors:  Wilke M Post; Joanna Widomska; Hilde Grens; Marieke J H Coenen; Frank M J Martens; Dick A W Janssen; Joanna IntHout; Geert Poelmans; Egbert Oosterwijk; Kirsten B Kluivers
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.